The company
Cytosorbents Corporation
CTSO · Nasdaq
CTSO stood above a rising 150-day average in 0 of the last 52 weekly readings. It is 217.3% above that average now. Medical Devices: 27% of its 181 stocks in an uptrend (−9 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- In trend
- Weeks in an uptrend
- out for 52
- Industry in uptrend
- 27% -9 in 4 wk
- Insider buys, 12 months
- $539K
- Insider sales, 12 months
- $0
- Officials’ trades on record
- 0
- Institutions holding
- 48 (+0)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 0 of 52 weeks.
Medical Devices: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Alan D. SobelDirector | bought | 1,900at $6.12 | 15 Sep 2026filed 16 Sep 2026 |
| Alan D. SobelDirector | bought | 500at $6.05 | 15 Sep 2026filed 16 Sep 2026 |
| Alan D. SobelDirector | bought | 100at $6.01 | 15 Sep 2026filed 16 Sep 2026 |
| Phillip P. ChanChief Executive Officer | bought | 3,774at $6.00 | 15 Sep 2026filed 16 Sep 2026 |
| Vincent CapponiPresident and COO | bought | 1,800at $6.07 | 14 Sep 2026filed 16 Sep 2026 |
| Vincent CapponiPresident and COO | bought | 273at $5.90 | 14 Sep 2026filed 16 Sep 2026 |
| Phillip P. ChanChief Executive Officer | bought | 200,000at $0.35 | 4 Sep 2026filed 9 Sep 2026 |
| Phillip P. ChanChief Executive Officer | bought | 10,333at $0.43 | 15 Jun 2026filed 15 Jun 2026 |
| Peter J. MarianiChief Financial Officer | bought | 100,000at $0.44 | 15 Jun 2026filed 16 Jun 2026 |
| Phillip P. ChanChief Executive Officer | bought | 251,136at $0.40 | 12 Jun 2026filed 15 Jun 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| AVENIR CORPreduced · filed 13 Aug 2026 | 5,189,218$1.9M | -26,558−0.5% |
| NEUBERGER BERMAN GROUP LLCadded · filed 13 Aug 2026 | 1,968,691$741K | +285,684+17.0% |
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 1,914,063$716K | +34,074+1.8% |
| CM Management, LLCunchanged · filed 13 Aug 2026 | 1,476,500$552K | 00.0% |
| Skylands Capital, LLCreduced · filed 24 Jul 2026 | 1,211,400$453K | -496,098−29.1% |
| BlackRock, Inc.reduced · filed 7 Aug 2026 | 627,211$235K | -155,781−19.9% |
| GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 2026 | 602,059$225K | -105,203−14.9% |
| Sargent Investment Group, LLCadded · filed 11 Aug 2026 | 555,757$208K | +5,857+1.1% |
| Pathstone Holdings, LLCreduced · filed 13 Aug 2026 | 499,910$187K | -450.0% |
| VANGUARD FIDUCIARY TRUST COadded · filed 13 Aug 2026 | 316,167$118K | +2,311+0.7% |
News
No headline names it lately.
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.